Yahoo! Finance Search - Finance Home - Yahoo! - Help

Wednesday, August 20 2014 12:43pm ET - U.S. Markets close in 3 hours and 17 minutes.
Industry Center - Drugs - Generic
Industry Center > Drugs - Generic > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Drugs - Generic News
Latest News
Wednesday, Aug 20, 2014
·U.S. judge blocks FDA rule allowing generic versions of Hospira drug
Reuters - 10 minutes ago
·SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Reminds Investors of Class Action Against Galectin Therapeutics Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 29, 2014 -- GALT
GlobeNewswire - 14 minutes ago
·[$$] Mylan Edges Toward Glaxo Drugs
at The Wall Street Journal Online - 38 minutes ago
·[$$] Hospira Wins Delay Against FDA
at The Wall Street Journal Online - 2 hours, 34 minutes ago
·Zoetis to Participate in Bank of America Merrill Lynch Global Healthcare Conference
Business Wire - Wed 8:30 am ET
·Should You Get Rid of Corium International (CORI) Now? - Wed 6:48 am ET
Tuesday, Aug 19, 2014
·[$$] Hospira Sues FDA Over Generic Precedex
at The Wall Street Journal Online - Tue 5:52 pm ET
·Salix Climbs to High on Report of Approach From Allergan
at Bloomberg - Tue 2:08 pm ET
·Allergan seeks deal with Salix to fend off Valeant - WSJ
Reuters - Tue 2:02 pm ET
·Why Hospira (HSP) Stock Is Lower Today
at - Tue 1:52 pm ET
·Mylan Launches Generic Precedex™ Injection - Another Key Product Approval
PR Newswire - Tue 11:42 am ET
·Supernus to Attend FBR HealthCare Conference in September
GlobeNewswire - Tue 10:00 am ET
·Mallinckrodt Now a Component of the S&P 500 Index
Business Wire - Tue 9:20 am ET
·Celator(R) Pharmaceuticals Initiates Pharmacokinetic and Pharmacodynamics Clinical Study of CPX-351
GlobeNewswire - Tue 8:30 am ET
·Actavis Announces Positive Topline Results From The Phase III Program Of Ceftazidime-Avibactam In Patients With Complicated Intra-Abdominal Infections(cIAI)
PR Newswire - Tue 7:24 am ET
·Salix Announces Early Termination of HSR Waiting Period for Pending Transaction
Business Wire - Tue 7:00 am ET
Monday, Aug 18, 2014
·Fibrocell Science, Inc. to Move Stock Listing to NASDAQ
Business Wire - Mon 4:05 pm ET
·Mallinckrodt Acquires Questcor, to Join S&P 500 As Well - Mon 3:30 pm ET
·Supernus's SPN-810 Gets Fast Track Status for ADHD - Mon Aug 18
·Others Overlooked Supernus Pharmaceuticals (SUPN), Should You Buy It Now? - Mon Aug 18
More Latest News...
Sponsor Results
Professional Statistician
All areas of research. Free initial consultation. 877-461-7226
Clinical Study Start-up
Accelerate clinical trial start-up, site selection, and recruitment.
Actuary Jobs D.W. Simpson
Worldwide actuarial recruitment company. See our salary surveys, too.
(What's This?)

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drugs - Generic Headlines
More Finance RSS Feeds

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?